News Focus
News Focus
Replies to #80831 on Biotech Values
icon url

genisi

07/14/09 3:27 PM

#80833 RE: masterlongevity #80831

Even if Tarceva gets approved for maintenance (and it probably will), I don't think docs will use it, they will probably stick to the old way of taking the patient off the drug and use 2nd line after progression.